» Articles » PMID: 9462507

Redundant Regulation of T Cell Differentiation and TCRalpha Gene Expression by the Transcription Factors LEF-1 and TCF-1

Overview
Journal Immunity
Publisher Cell Press
Date 1998 Feb 14
PMID 9462507
Citations 133
Authors
Affiliations
Soon will be listed here.
Abstract

Lymphoid enhancer factor 1 (LEF-1) and T cell factor 1 (TCF-1) are closely related transcription factors that are both expressed during murine T cell differentiation and that regulate the T cell receptor alpha (TCRalpha) enhancer in transfection assays. Targeted gene disruption of either the Tcf1 or Lef1 gene in mice did not affect TCRalpha gene expression and resulted in an incomplete defect or no defect in thymocyte differentiation. Here, we examine a potential redundancy of these transcription factors by analyzing double-mutant mice. In fetal thymic organ cultures from Lef1-/- Tcf1-/- mice, alpha/beta T cell differentiation is completely arrested at the immature CD8+ single-positive (CD8+ ISP) stage and is markedly impaired at an earlier stage. In addition, we find that sorted CD8+ ISP cells from Lef1-/- Tcf1-/- mice express TCRbeta but show a severely reduced level of TCRalpha gene transcription. Together, these data show that LEF-1 and TCF-1 are redundant in the regulation of T cell differentiation and gene expression.

Citing Articles

Enhancers in T Cell development and malignant lesions.

Zhang T, Zou L Cell Death Discov. 2024; 10(1):406.

PMID: 39284807 PMC: 11405840. DOI: 10.1038/s41420-024-02160-7.


Transcriptional network dynamics in early T cell development.

Shin B, Chang S, MacNabb B, Rothenberg E J Exp Med. 2024; 221(10).

PMID: 39167073 PMC: 11338287. DOI: 10.1084/jem.20230893.


Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia.

Mulet-Lazaro R, van Herk S, Nuetzel M, Sijs-Szabo A, Diaz N, Kelly K Nat Commun. 2024; 15(1):5693.

PMID: 38972954 PMC: 11228033. DOI: 10.1038/s41467-024-49811-y.


Identification of master regulator genes controlling pathogenic CD4 T cell fate in inflammatory bowel disease through transcriptional network analysis.

Jimenez J, Contreras-Riquelme J, Vidal P, Prado C, Bastias M, Meneses C Sci Rep. 2024; 14(1):10553.

PMID: 38719901 PMC: 11078927. DOI: 10.1038/s41598-024-61158-4.


A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma.

Zhu W, Zhang Z, Chen J, Chen X, Huang L, Zhang X Signal Transduct Target Ther. 2024; 9(1):101.

PMID: 38643203 PMC: 11032311. DOI: 10.1038/s41392-024-01792-6.